| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |